Effective August 3, 2015, Baylor Miraca Genetics Laboratories (BMGL) will begin performing BRCA1 & BRCA2 sequencing analysis as an in-house test. As a result, BMGL will discontinue use of the following test code:
- Test code 1220 – BRCA1/2 Sequence & Deletion/Duplication Analysis
For all new orders, please use the following test code, which will replace test code 1220:
- Test code 22350 – BRCA1 & BRCA2 Comprehensive Panel – NGS
Baylor Genetics
Baylor Genetics is a joint venture of H.U. Group Holdings and the #1 NIH-funded genetics program at Baylor College of Medicine. A pioneer of precision medicine for nearly 40 years, Baylor Genetics now offers a full spectrum of clinically relevant genetic testing, access to world-renowned experts, and the confidence to provide patients with the best care. Baylor Genetics, located in Houston’s Texas Medical Center, serves clients in 50 states and 16 countries.
